Tags: Drug.

Tafamidis (INN or Fx-1006A trade name Vyndaqel) is a drug for the amelioration of transthyretin-related hereditary amyloidosis (also familial amyloid polyneuropathy or FAP) a rare but deadly neurodegenerative disease.

Tafamidis_skeletal.svg
ATC prefix
N07
ATC suffix
XX08
CAS number
594839-88-0
FDA UNII code
8FG9H9D31J
IUPAC name
2-(35-dichlorophenyl)-13-benzoxazole-6-carboxylic acid
PubChem
11001318

Loading...

This page contains content from the copyrighted Wikipedia article "Tafamidis"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.